TERT and cancer: GV1001 vaccination was evaluated in different cancer types either alone or in combination with MHC-I (HLA-A2.1) TERT peptides (p540) in granulocyte macrophage-colony stimulating factor (GM-CSF) adjuvant, with or without chemotherapy [62].